Fulcrum Therapeutics Inc Cash Flow Quality Index
Latest as of June 2024:
1.06x
Fulcrum Therapeutics Inc cash flow quality index. Fulcrum Therapeutics Inc (FULC) has a Cash Flow Quality Index of 1.06x as of June 2024. Operating cash flow of $58.90 Million exceeds net income of $55.41 Million, indicating high earnings quality where cash backs reported profits. See Fulcrum Therapeutics Inc (FULC) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
1.06x
Operating CF / Net Income
Operating Cash Flow
$58.90 Million
USD
Net Income
$55.41 Million
USD
Data as of
Jun 2024
Most recent filing
Fulcrum Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Fulcrum Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Fulcrum Therapeutics Inc. For the full cash flow conversion analysis, see FULC cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.